| Financial Year |
March 31 2023 |
| Monetary Funds |
896,548,635.93 |
| Held-for-trading Financial Assets |
30,420,254.35 |
| Notes Receivable |
15,003,560.87 |
| Accounts Receivable |
758,333,476.72 |
| Advances to Suppliers |
52,465,299.17 |
| Other Receivables |
31,160,854.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
123,036,310.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,544,888.79 |
| Total Current Assets |
1,987,258,550.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
157,866,824.91 |
| Investment Properties |
-- |
| Fixed Assetes |
252,744,841.85 |
| Under-construction Projects |
115,909,897.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
118,835,420.06 |
| R&D expenses |
215,951,959.01 |
| Goodwill |
171,379,942.79 |
| Long-Term Deferred and Prepaid Expenses |
6,061,035.98 |
| Deferred Income Tax Assets |
51,419,479.98 |
| Other Non-Current Assets |
141,391.21 |
| Sub-Total of Non-Current Assets |
1,355,380,836.91 |
| Total Assets |
3,342,639,387.36 |
| Short-Term Loans |
130,121,388.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
87,594,755.24 |
| Accounts Received In Advance |
1,024,215.02 |
| Employee Compensation Payable |
121,956,592.98 |
| Taxes Payable |
70,816,821.02 |
| Interest Payable |
-- |
| Dividend Payable |
1,800,897.80 |
| Other payables |
13,779,166.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
45,033,667.28 |
| Other Current Liabilities |
4,371,247.31 |
| Sub-Total of Current Liabilities |
532,775,935.62 |
| Long-term Loans |
168,635,726.72 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
998,754.02 |
| Other Non-Current Liabilities |
14,833,174.20 |
| Sub-Total of Non-Current Liabilities |
227,218,548.04 |
| Total Liabilities |
759,994,483.66 |
| Paid-In Capital(Or Share Stock) |
403,863,849.00 |
| Capital Surplus |
1,205,717,988.64 |
| Surplus Reserve |
65,280,285.18 |
| LESS:Treasury Stock |
50,186,738.92 |
| Undistributed Profits |
770,491,416.14 |
| Minority Stockholder's Interest |
176,662,523.79 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,405,982,379.91 |
| Owner's Equity（Stockholder's Equity） |
2,582,644,903.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,342,639,387.36 |
